Association between different dual trigger dosages and in vitro fertilization results in patients with patientoriented strategies encompassing individualized oocyte number group IV

키워드

참고문헌 (29)

1. Ascoli M, "The lutropin", choriogonadotropin receptor, a 2002 perspective, 2002, pp.23, 141~174
2. Ludwig M, "Use of recombinant human chorionic gonadotropin in ovulation induction", Fertil Steril, 79, pp.1051~1059 (2003)
3. Decleer W, "Comparison of hCG triggering versus hCG in combination with a GnRH agonist : a prospective randomized controlled trial", Facts Views Vis Obgyn, 6, pp.203~209 (2014)
4. Gonen Y, "Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization", J Clin Endocrinol Metab, 71, pp.918~922 (1990)
5. Itskovitz J, "Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist", Fertil Steril, 56, pp.213~220 (1991)
6. Youssef MA, "Gonadotropinreleasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles", Cochrane Database Syst Rev, (1), pp.CD008046~ (2011)
7. Kummer NE, "Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist(GnRHa)trigger", Hum Reprod, 28, pp.152~159 (2013)
8. Shapiro BS, "Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization", Fertil Steril, 90, pp.231~233 (2008)
9. Shapiro BS, "Comparison of"triggers"using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin", Fertil Steril, 95, pp.2715~2717 (2011)
10. Lin MH, "Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles", Fertil Steril, 100, pp.1296~1302 (2013)
11. Humaidan P, "GnRH agonist(buserelin)or hCG for ovulation induction in GnRH antagonist IVF", ICSI cycles : a prospective randomized study, 2005, pp.20, 1213~1220
12. Esteves SC, "Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why", Front Endocrinol(Lausanne), 9, pp.461~ (2018)
13. Ferraretti AP, "ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization : the Bologna criteria", Hum Reprod, 26, pp.1616~1624 (2011)
14. Humaidan P, "The novel POSEIDON stratification of ‘low prognosis patients in assisted reproductive technology’ and its proposed marker of successful outcome", F1000Res, 5, pp.2911~ (2016)
15. Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), "A new more detailed stratification of low responders to ovarian stimulation : from a poor ovarian response to a low prognosis concept", Fertil Steril, 105, pp.1452~1453 (2016)
16. Ding N, "Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization : a systematic review and meta-analysis", Eur J Obstet Gynecol Reprod Biol, 218, pp.92~98 (2017)
17. Zhou X, "Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders", Int J Gynaecol Obstet, 141, pp.327~331 (2018)
18. Chern CU, "Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve : a retrospective cohort study", PLoS One, 15, pp.e0235707~ (2020)
19. Van Royen E, "Characterization of a top quality embryo, a step towards singleembryo transfer", Hum Reprod, 14, pp.2345~2349 (1999)
20. Gardner Y, "Towards reproductive certainty: fertility and genetics beyond", pp.377~388 (1999), Parthenon Publishing
21. Orvieto R, "Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?", J Ovarian Res, 8, pp.60~ (2015)
22. Zilberberg E, "Co-administration of GnRH-agonist and hCG, for final oocyte maturation(double trigger), in patients with low proportion of mature oocytes", Gynecol Endocrinol, 31, pp.145~147 (2015)
23. Griffin D, "Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates", Fertil Steril, 102, pp.405~409 (2014)
24. Hsieh M, "Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation", Mol Cell Biol, 27, pp.1914~1924 (2007)
25. Park JY, "EGF-like growth factors as mediators of LH action in the ovulatory follicle", Science, 303, pp.682~684 (2004)
26. Huang Y, "Altered amphiregulin expression induced by diverse luteinizing hormone receptor reactivity in granulosa cells affects IVF outcomes", Reprod Biomed Online, 30, pp.593~601 (2015)
27. Şükür Yavuz Emre, "Dual trigger in normally-responding assisted reproductive technology patients increases the number of top-quality embryos", Clinical and Experimental Reproductive Medicine, 46(4), pp.300~305 (2020), 대한생식의학회[DOI]
28. Zeleznik AJ, "Granulosa cell maturation in the rat : increased binding of human chorionic gonadotropin following treatment with folliclestimulating hormone in vivo", Endocrinology, 95, pp.818~825 (1974)
29. Richards JS, "Ovarian follicular development in the rat : hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone", Endocrinology, 99, pp.1562~1570 (1976)

관련 논문AI추천